A genome-wide association study of nearly 60 quantitative traits highlighted the links between genes, clinical measurements, and disease.
Riken researchers conducting a trial of an iPS cell treatment of age-related macular degeneration say a patient experienced swelling, according to the Japan Times.
Such an atlas could enable investigators to understand how genetic variants impact disease risk, define drug toxicities, improve therapies, and advance regenerative medicine.
In Nature this week: genomic regions affecting parental care in mice, and more.
A pair of studies also uncovered atrial fibrillation risk loci specific to East Asian populations, particularly near SH3PXD2A.
The FANTOM consortium generated an atlas of nearly 30,000 human long non-coding RNAs that suggests more than 19,000 of them are functional.
The researchers will use single-cell genomics and other approaches to generate information that could ultimately be used to diagnose, monitor, and treat disease.
A team of researchers has characterized the mutations commonly found in liver cancer, and suggests that the disease may be genomically heterogeneous.
Through a genome-wide association study, a team of researchers from Riken uncovered three loci linked to peripheral artery disease susceptibility.
Two new studies appearing in Nature fail to replicate the findings of the discredited STAP papers.
Germany's Project DEAL has come to an agreement with the publisher Wiley over journal access and open-access publishing, ScienceInsider reports.
Researchers uncover additional loci associated with lifespan, which the Telegraph says could be folded into a genetic test.
A Canadian panel recommends public coverage of the gene therapy Kymriah if its cost comes down, the Globe and Mail reports.
In Nucleic Acids Research this week: new accurate quantification by sequencing approach, CNV breakpoints in Plasmodium falciparum, and more.